Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 3946 AL 3960

Posterior cortical atrophy: an atypical variant of Alzheimer disease

Suárez-González A, Henley SM, Walton J, Crutch SJ.

Psychiatr Clin North Am. 2015 Jun;38(2):211-20. doi: 10.1016/j.psc.2015.01.009. Epub 2015 Mar 12.

The neuropsychiatric examination of the young-onset dementias

Ducharme S, Dickerson BC.

Psychiatr Clin North Am. 2015 Jun;38(2):249-64. doi: 10.1016/j.psc.2015.01.002. Epub 2015 Mar 12.

Neuropsychiatric management of young-onset dementias

Shinagawa S.

Psychiatr Clin North Am. 2015 Jun;38(2):323-31. doi: 10.1016/j.psc.2015.01.004. Epub 2015 Feb 27.

The CARE pathway model for dementia: psychosocial and rehabilitative strategies for care in young-onset dementias

Morhardt D, Weintraub S, Khayum B, Robinson J, Medina J, O'Hara M, Mesulam M, Rogalski EJ.

Psychiatr Clin North Am. 2015 Jun;38(2):333-52. doi: 10.1016/j.psc.2015.01.005. Epub 2015 Mar 7.

Progressive changes in artistic performance of a Chinese master with Alzheimer's disease

Lee YT, Tsai YC, Chen LK.

Cortex. 2015 Aug;69:282-3. doi: 10.1016/j.cortex.2015.04.009. Epub 2015 May 1.

Emotion recognition in frontotemporal dementia and Alzheimer's disease: A new film-based assessment

Goodkind MS, Sturm VE, Ascher EA, Shdo SM, Miller BL, Rankin KP, Levenson RW.

Emotion. 2015 Aug;15(4):416-27. doi: 10.1037/a0039261. Epub 2015 May 25.

Behind the faces: Alzheimer's disease and emotional blindness

Smid J, Adoni T.

Arq Neuropsiquiatr. 2015 May;73(5):381-2. doi: 10.1590/0004-282X20150060.

[How to recognize pain in patients with dementia]

Kunz M, Lautenbacher S.

MMW Fortschr Med. 2015 May 28;157(10):72-4. doi: 10.1007/s15006-015-3140-0.

Effects of noninvasive brain stimulation on cognitive function in healthy aging and Alzheimer's disease: a systematic review and meta-analysis

Hsu WY, Ku Y, Zanto TP, Gazzaley A.

Neurobiol Aging. 2015 Aug;36(8):2348-59. doi: 10.1016/j.neurobiolaging.2015.04.016. Epub 2015 May 1.

Neuronal histamine and cognitive symptoms in Alzheimer's disease

Zlomuzica A, Dere D, Binder S, De Souza Silva MA, Huston JP, Dere E.

Neuropharmacology. 2016 Jul;106:135-45. doi: 10.1016/j.neuropharm.2015.05.007. Epub 2015 May 27.

Editorial: Prevention Strategies Targeting Different Preclinical Stages of Alzheimer's Disease

Zhou B.

Curr Alzheimer Res. 2015;12(6):504-6. doi: 10.2174/1567205012666150530202923.

The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer's Disease

Deardorff WJ, Feen E, Grossberg GT.

Drugs Aging. 2015 Jul;32(7):537-47. doi: 10.1007/s40266-015-0273-x.

Safety and pharmacokinetics of bapineuzumab in a single ascending-dose study in Japanese patients with mild to moderate Alzheimer's disease

Arai H, Umemura K, Ichimiya Y, Iseki E, Eto K, Miyakawa K, Kirino E, Shibata N, Baba H, Tsuchiwata S.

Geriatr Gerontol Int. 2016 May;16(5):644-50. doi: 10.1111/ggi.12516. Epub 2015 Jun 4.

Neuropsychiatric symptoms in Alzheimer's disease: What might be associated brain circuits?

Rosenberg PB, Nowrangi MA, Lyketsos CG.

Mol Aspects Med. 2015 Jun-Oct;43-44:25-37. doi: 10.1016/j.mam.2015.05.005. Epub 2015 Jun 3.

Reduced uptake of 18F-FDG and 15O-H2O in Alzheimer's disease-related regions after glucose loading

Ishibashi K, Kawasaki K, Ishiwata K, Ishii K.

J Cereb Blood Flow Metab. 2015 Aug;35(8):1380-5. doi: 10.1038/jcbfm.2015.127. Epub 2015 Jun 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias